secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK:        0000882796
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0001171843-25-000112
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCryst raises ORLADEYO WAC 5% to $44,484.33 per 28-day pack effective Jan 8
-----------------------------------------------------------------------------

- ORLADEYO WAC raised from $42,366.03 to $44,484.33 per 28-day pack (150mg or 110mg).
- Price increase of approximately 5% effective January 8, 2025.
- The WAC increase applies to both the 150mg and 110mg capsule packs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882796/000117184325000112/0001171843-25-000112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882796/000117184325000112/f8k_010824.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-000112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer